Let’s talk about Titiminas Silver (TITI.V), which just published its first metallurgical test results from the Madre Sierra Silver mine and the Madre Sierra Norte vein system at its Peruvian flagship project. The company expects to produce three concentrates at Madre Sierra and a single copper-silver concentrate at Madre Sierra Norte.
Now, before anyone gets misty-eyed about “recoveries,” remember what this actually is: the first test run. Not a bankable feasibility study. Not even a PEA. A first metallurgical pass, with additional work still needed on cleaning and arsenic rejection to make the concentrates actually payabile by cutting impurities. Arsenic rejection is not a nice-to-have in this business—it’s the difference between a smelter paying you a premium and a smelter charging you a penalty, or refusing your material outright. The company hasn’t solved that problem yet. It has acknowledged it. Credit for honesty; no credit yet for results.
The real economic inputs from this test work will feed into the preliminary economic assessment for the Sierra Madre project, expected in Q4 of next year. Sit with that timeline for a second. A year out. Which means for the next twelve months, the investment case for this stock rests on press releases describing tests, not on cash flows, reserves, or a single independently verified economic number. That’s not an investment; that’s a narrative with a ticker.
And here’s the math the promoters never do for you: if a junior miner’s PEA is a year away, you’re paying today’s price for a document that doesn’t exist, based on recovery figures that may improve—or evaporate—once arsenic rejection and concentrate cleaning are actually optimized. Every month of delay dilutes your annualized return, and every subsequent financing to fund “additional metallurgical work” dilutes your equity. Junior mining dilution is the most reliable compounder in finance—just pointed in the wrong direction.
The disclosure on this piece says the author has no position but may initiate one soon. Keep that incentive structure in mind whenever someone writes glowing prose about test results from a company they’re about to buy. It’s not automatically disqualifying, but it does mean the enthusiasm was pre-loaded.
None of this says the project is worthless. Metallurgy that produces marketable concentrates is a genuine de-risking step, and arsenic management being addressed early rather than hand-waved is a point in the company’s favor. But “a point in the company’s favor” is not a reason to own a pre-PEA junior with your retirement money. Position sizing exists precisely for this: if you must speculate here, it’s money you could light on fire without changing your FIRE date. Your index funds don’t care about arsenic rejection schedules. Your withdrawal rate does care if you bet 20% of your portfolio on a Q4 PEA.
Discipline is buying the boring whole market and letting compound interest do the actual work. Speculation is fine—sized like speculation. The difference between a calculated bet and a lottery ticket is position size and an exit plan, and most people holding pre-PEA juniors have neither.
The PEA arrives when it arrives. Your savings rate doesn’t wait for anyone.
Source: https://www.caesarsreport.com/blog/titiminas-silver-reports-on-metallurgical-test-results/
